The Russian Ministry of Health announced yesterday that doctors at the National Medical Research Center for Radiology administered the country’s first domestically developed personalized mRNA-based cancer vaccine. The patient who received the vaccine is a 60-year-old melanoma patient. Neooncovac, is the first domestically developed personalized mRNA-based cancer vaccine. First Test Batches of Russia’s AI-assisted Cancer Vaccine Have Been Created According to Doolly, his therapeutic vaccine, created using the patient’s unique tumor-specific mutations and molecular-genetic characteristics, works as an individualized anti-tumor treatment by encoding neoantigens into mRNA delivered via lipid nanoparticles. It trains the immune system to mount a targeted T-cell…

Newswire

Features

The Latest

Editor's Picks